Le Lézard
Classified in: Health
Subject: BFA

In Case You Missed It: Multimedia Now Available to Learn More About Light Chain (AL) Amyloidosis and a New Treatment Option


HORSHAM, Pa., Jan. 19, 2021 /PRNewswire/ -- Learn about light chain (AL) amyloidosis and a new treatment option for this rare and serious blood cell disorder.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8829551-janssen-light-chain-al-amyloidosis/

Media contacts:
Bernadette King
Phone: +1 215-778-3027

Satu Glawe
Phone: +49 172-294-6264

Investor Relations:
Jennifer McIntyre
Phone: +1 732-524-3922

U.S. Medical Inquiries:
+1 800-526-7736

SOURCE Janssen Pharmaceutical Companies of Johnson & Johnson


These press releases may also interest you

at 12:30
American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...

at 12:00
Adhering to Asthma Medication is Safe for Pregnant Women with Asthma
Maintaining asthma medication and asthma control leads to safer perinatal outcomes for pregnant women according to new research published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), an official journal of the...

at 11:45
Annals of Internal Medicine presents breaking scientific news at ACP's Internal Medicine Meeting 2024
Today at ACP's annual meeting, Internal Medicine Meeting 2024, Annals of Internal Medicine presented three breaking scientific research articles during a live scientific plenary session that featured the authors of those articles. The articles were...

at 11:43
Cochlear receives FDA clearance to lower the age for the Osia System to 5-years-old
- Cochlear Limited , the global leader in implantable hearing...

at 11:35
Bone Health and Osteoporosis Foundation Announces Call for Nominees for New Robert F. Gagel, M.D. Community Leadership Award
The Bone Health and Osteoporosis Foundation (BHOF) announced today its call for nominees for the newly created Robert F. Gagel, M.D. Community Leadership Award. The award's intent is to recognize healthcare professionals who are instrumental in...

More news about Health...


News published on and distributed by: